Edrophonium chloride

Overview

Edrophonium chloride is a short-acting acetylcholinesterase ( AChE ) inhibitor. Edrophonium chloride has K i values of 0.2, 0.2, and 0.4 μM and IC 50 values of 0.2, 0.05, and 0.5 μM for AChE in human erythrocytes, purified calf forebrain, and purified octopus brain, respectively. Edrophonium chloride can be used to detect early digitalis toxicity and in the study of myasthenia gravis.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Cholinesterase (ChE)

Product Information

• Catalog No.: HY-B0882
• CAS No.: 116-38-1
• Molecular Formula: C10H16ClNO
• Molecular Weight: 201.69
• Purity: 98.68%
• Storage: -20°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.08 mg/mL (10.31 mM); Clear solution
• Availability: In-stock

Source

Original product source